August 3, 2005 – Federal Register Recent Federal Regulation Documents

In accordance with the Federal Advisory Committee Act (Pub. L. 92-463, 86 Stat. 770, 5 U.S.C. App 1, section 10), notice is hereby given that the Concessions Management Advisory Board (the Board) will hold its 14th meeting on August 25, 2005, at Grand Teton National Park, Moose, Wyoming. The meeting will be held at the Jackson Lake Lodge in Grand Teton National Park. The meeting will convene at 8:30 a.m. and will conclude at 4:30 p.m.

The Defense Logistics Agency is amending a system of records notice to its existing inventory of record systems subject to the Privacy Act of 1974 (5 U.S.C. 552a), as amended.

The Defense Threat Reduction Agency is deleting a system of records notice from its existing inventory of records systems subject to the Privacy Act of 1974 (5 U.S.C. 552a), as amended.

The inventions listed below are owned by an agency of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 207 to achieve expeditious commercialization of results of federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing.

This notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), announces that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive license to practice the inventions embodied in 1. E-199-2002/0-US-01, ``Treatment Method and Therapeutic Agent of Kidney Cancer'', by Susan Bates, and Yoshinori Naoe, Pat. Application No. 60/369,868 (filing date April 5, 2002); 2. E-199-2002/0-PCT-02, ``Treatment Method and Therapeutic Agent of Kidney Cancer'', by Susan Bates, and Yoshinori Naoe, Pat. Application No. PCT/US03/03823 (filing date March 27, 2003); 3. E-199-2002/0-US-04, ``Depsipeptide for Therapy of Kidney Cancer'', by Susan Bates, and Yoshinori Naoe, Pat. Application No. 10/ 508,958 (filing date October 5, 2004); 4. E-199-2002/0-JP-08, ``Depsipeptide for Therapy of Kidney Cancer'', by Susan Bates, and Yoshinori Naoe, Pat. Application No. 20003581847 (filing date October 5, 2004); 5. E-199-2002/0-EP-05, ``Depsipeptide for Therapy of Kidney Cancer'', by Susan Bates, and Yoshinori Naoe, Pat Application No.037155033-2107 (filing date October 8, 2004); 6. E-286-2000/0-US-01, ``Histone Deacetylase Inhibitors in Diagnosis and Treatment of Thyroid Neoplasms'', by Tito Fojo and Susan Bates, Pat. Application No. 60/260,733 (filing date January 10, 2001); 7. E-286-2000/0-US-02, ``Histone Deacetylase Inhibitors in Diagnosis and Treatment of Thyroid Neoplasms'', by Tito Fojo and Susan Bates, Pat. Application No. PCT/US02/0714 (filing date January 9, 2001); 8. E-286-2000/0-EP-03, ``Histone Deacetylase Inhibitors in Diagnosis and Treatment of Thyroid Neoplasms'', by Tito Fojo and Susan Bates, Pat. Application No. 02718823.4 (filing date January 9, 2001); 9. E-286-2000/0-AU-04, ``Histone Deacetylase Inhibitors in Diagnosis and Treatment of Thyroid Neoplasms'', by Tito Fojo and Susan Bates, Pat. Application No. 2002249938 (filing date January 9, 2001); 10. E-286-2000/0-CA-04, ``Histone Deacetylase Inhibitors in Diagnosis and Treatment of Thyroid Neoplasms'', by Tito Fojo and Susan Bates, Pat. Application No. 2434269 (filing date January 9, 2001); 11. E-286-2000/0-US-07, ``Histone Deacetylase Inhibitors in Diagnosis and Treatment of Thyroid Neoplasms'', by Tito Fojo and Susan Bates, Pat. Application No. 10/250,320 (filing date June 26, 2003); 12. E-286-2000/0-JP-05, ``Histone Deacetylase Inhibitors in Diagnosis and Treatment of Thyroid Neoplasms'', by Tito Fojo and Susan Bates, Pat. Application No. 2002-556736 (filing date July 10, 2003)

This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of Health (NIH), Department of Health and Human Services, is contemplating the grant of an exclusive license to practice the invention embodied in U.S. provisional patent application, S/N 60/569,819 filed May 11, 2004, entitled ``Methods for Inhibiting Proinflammatory Cytokine Expression Using Ghrelin'' and converted to PCT on May 11, 2005 (E-016-2004/0-PCT- 02), [Inventors: Vishwa D. Dixit, Dennis D. Taub, Eric Schaffer, and Dzung Nguyen (NIA)], to Gastrotech Pharma (hereafter Gastrotech), having a place of business in Copenhagen, Denmark. The patent rights in these inventions have been assigned to the United States of America.

NMFS is prohibiting retention of ``other rockfish'' in the Central Regulatory Area of the Gulf of Alaska (GOA). NMFS is requiring that catch of ``other rockfish'' in this area be treated in the same manner as prohibited species and discarded at sea with a minimum of injury. This action is necessary because the ``other rockfish'' 2005 total allowable catch (TAC) in this area has been reached.

In this action, EPA is proposing to correct an error in the notice which approved the removal of Oregon's control technology guidelines for perchloroethylene (perc) dry cleaning systems and related definitions and provisions, published on December 1, 2004. Perc is a solvent commonly used in dry cleaning, maskant operations, and degreasing operations. In the notice published on December 1, 2004 (69 FR 69823), EPA inadvertently listed an incorrect State effective date in the incorporation by reference section which listed revised provisions of the Oregon Administrative Rules. This proposed action would correct the erroneous date so that the appropriate version of the Oregon Administrative Rules is incorporated by reference.

EPA is revoking certain tolerances for residues of the herbicide alachlor, insecticides carbaryl, diazinon, disulfoton, and pirimiphos-methyl, and the fungicide vinclozolin because these specific tolerances are no longer needed or are associated with food uses that are no longer current or registered in the United States. The regulatory actions in this document contribute toward the Agency's tolerance reassessment requirements of the Federal Food, Drug, and Cosmetic Act (FFDCA) section 408(q), as amended by the Food Quality Protection Act (FQPA) of 1996. By law, EPA is required by August 2006 to reassess the tolerances in existence on August 2, 1996. The regulatory actions in this document pertain to the revocation of 15 tolerances of which 9 count as tolerance reassessments toward the August, 2006 review deadline.

EPA's Pesticide Program Dialogue Committee (PPDC), Pesticide Registration Improvement Act (PRIA) Process Improvement Workgroup will hold a public meeting on September 14, 2005. An agenda for this meeting is being developed and should be posted on EPA's website in mid-August. The workgroup is developing advice and recommendations on topics related to EPA's registration process.

In accordance with section 6(f)(1) of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), EPA announced in theFederal Register of July 15, 2005, a notice of receipt of an irrevocable request by the Hartz Mountain Corporation to voluntarily cancel EPA Registration Number 2596-148. The document inadvertently omitted a sentence from the DATES unit and omitted theADDRESSES unit. This document corrects those errors.

In compliance with the Paperwork Reduction Act (44 U.S.C. 3501 et seq.), this document announces that an Information Collection Request (ICR) has been forwarded to the Office of Management and Budget (OMB) for review and approval: Application for New and Amended Pesticide Registration; EPA ICR Number 0277.14; OMB Control Number 2070-0060. The ICR, which is abstracted below, describes the nature of the information collection activity and its expected burden and costs.

EPA is updating the materials submitted by the Commonwealth of the Northern Mariana Islands that are incorporated by reference (IBR) into the Commonwealth of the Northern Mariana Islands State Implementation Plan (SIP). The regulations affected by this update have been previously submitted by the territorial agency and approved by EPA. This update affects the SIP materials that are available for public inspection at the Office of the Federal Register (OFR), Office of Air and Radiation Docket and Information, and the Regional Office.

This notice proposes to establish a Class E airspace area at Hana, HI. The establishment of an Area Navigation (RNAV) Global Positioning System (GPS) Instrument Approach Procedure (IAP) RNAV (GPS) to Runway (RWY) 26 IAP and a RNAV Departure Procedure (DP) at Hana Airport, Hana, HI has made this proposal necessary. Additional controlled airspace extending upward from 700 feet or more above the surface of the earth is needed to contain aircraft executing the RNAV (GPS) RWY 26 and RNAV DP at Hana Airport. The intended effect of this proposal is to provide adequate controlled airspace for Instrument Flight Rules (IFR) operations at Hana Airport, Hana, HI.

In compliance with the Paperwork Reduction Act of 1995 (44 U.S.C. 3501 et seq.), this notice announces that the Information Collection Requests (ICR) abstracted below have been forwarded to the Office of Management and Budget (OMB) for extension of the currently approved collections. The ICR describes the nature of the information collection and the expected burden. The Federal Register Notice with a 60-day comment period soliciting comments on the following collections of information was published on April 12, 2005, page 19144.

These special conditions are issued to Maule Aerospace Technology, Inc., for the Maule Aerospace Technology, Inc. M-7-230, M- 7-230C, and M-9-230 airplane models. These airplanes will have a novel or unusual design feature(s) associated with the installation of an engine that uses an electronic engine control system in place of the engine's mechanical system. The applicable airworthiness regulations do not contain adequate or appropriate safety standards for this design feature. These special conditions contain additional safety standards that the Administrator considers necessary to establish a level of safety equivalent to that established by the existing airworthiness standards applicable to these airplanes. These special conditions were issued and effective in December 2003; however, they were inadvertently not published. This document is being published with the same effective date to correct that oversight.

In accordance with the requirement of Section 3506 (c)(2)(A) of the Paperwork Reduction Act of 1995 which provides opportunity for public comment on new or revised data collections, the Railroad Retirement Board (RRB) will publish periodic summaries of proposed data collections. Comments are invited on: (a) Whether the proposed information collection is necessary for the proper performance of the functions of the agency, including whether the information has practical utility; (b) the accuracy of the RRB's estimate of the burden of the collection of the information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden related to the collection of information on respondents, including the use of automated collection techniques or other forms of information technology. Title and Purpose of information collection: Continuing Disability Report; OMB 3220-0187. Under Section 2 of the Railroad Retirement Act, an annuity is not payable or is reduced for any month in which the annuitant works for a railroad or earns more than prescribed dollar amounts from either non- railroad employment or self-employment. Certain types of work may indicate an annuitant's recovery from disability. The provisions relating to the reduction or non-payment of annuities by reasons of work and an annuitant's recovery from disability for work are prescribed in 20 CFR 220.17-220.20. The RRB conducts continuing disability reviews (CDR) to determine whether annuitants continue to meet the disability requirements of the law. Provisions relating to when and how often the RRB conducts CDR's are prescribed in 20 CFR 220.186. Form G-254, Continuing Disability Report, is used by the RRB to develop information for CDR determinations, including determinations prompted by a report of work, return to railroad service, allegations of medical improvement, or routine disability call-up. The RRB provides significant non-burden impacting editorial and formatting changes. The editorial changes are proposed largely to provide better instructions and to clarify information currently requested. Form G-254a, Continuing Disability Update Report, is used to help identify disability annuitants whose work activity and/or recent medical history warrants a more extensive review and thus completion of Form G-254. The RRB proposes non-burden impacting changes to Form G- 254a to delete items no longer necessary and to add the Paperwork Reduction Act/Privacy notice that had previously been part of an accompanying transmittal letter. One response is requested of each respondent to Form G-254 and G- 254a. Completion is required to retain a benefit.

The public is invited to comment on the following applications to conduct certain activities with endangered species and/or marine mammals.

We (Fish and Wildlife Service) plan to send the collection of information described below to OMB for approval under the provisions of the Paperwork Reduction Act. Information collected through the horseshoe crab tagging program will aid in managing and protecting this species.